716
N.T.T. Huong et al. / Steroids 74 (2009) 715–720
125.8/75 MHz for 13C), Varian Gemini 300 HC (300 MHz for 1H and
75 MHz for 13C) NMR spectrometer at 300 K if not stated otherwise.
The internal signal of tetramethylsilane (ı 0.0) for 1H and the central
line of solvent (ı 77.0) for 13C spectra were used as standards. Chem-
ical shifts are presented in ppm (ı), coupling constants in Hz (J). UV
spectra were taken on a Carey-300 UV-VIS spectrophotometer, CD
spectra were taken on a Jasco spectropolarimeter J-715 using quartz
cuvettes (path length l = 0.5 cm). Mass spectra were taken on a Q
TOF (Micromass) spectrometer with direct inlet (ESI), on a ZAB-EQ
(VG Analytical) instrument (FAB) with Xe ionization, or Autospec
Ultima (Micromass) by EI technique. As the source of microwave
(MW) irradiation a microwave microprocessor controlled chemical
reactor Plasmatronika M REOS with electromagnetic stirring, MW
generator of 2.45 GHz and temperature regulation was used.
31.25, 6; 28.45, 16; 27.45, 7; 24.43, 15; 24.11, 19; 21.12, 11; 18.52, 21;
12.29, 18.
2.2.2.2. Condensation with pyrrole with TFA. Trifluoroacetic acid
(8 l) was added to the mixture of methyl ester of 3-oxo-5--
cholan-24-oic acid (194 mg, 0.5 mmol) and pyrrole (2 ml, 3.01 g,
44 mmol) under argon and the mixture was stirred for 3 h at
room temperature. Then, the mixture was evaporated and co-
evaporated with toluene (3 × 1 ml). The residue was dissolved in
dichloromethane (20 ml), filtered through silica gel (10 g), and
washed with dichloromethane (50 ml). The filtrate was evaporated
and the residue chromatographed on a column of silica gel (27 g)
by cyclohexane: ether 9:1, yielding 3 (185 mg; 73%), as above.
2.2.3. Condensation of
methyl-3,3-bis(pyrrol-2-yl)-5ˇ-cholan-24-oate 3 with carbonyl
compounds
2.2. Chemical synthesis
2.2.3.1. General procedure. All reactions were performed under
inert atmosphere of argon using the vacuum line. Trifluoroacetic
acid was added under stirring to a mixture of methyl-3,3-bis(pyrrol-
2-yl)-5-cholan-24-oate 3 (0.5 mmol) and 10 equivalents of the
respective carbonyl compound in a suitable solvent were also
added. The reaction mixture was monitored by TLC and was stirred
until acceptable conversion. Then, dry Na2CO3 was added and, after
filtration, the filtrate was evaporated to dryness. The rough product
was purified by column chromatography on silica gel.
2.2.1. Esterification and subsequent oxidation of lithocholic acid 1
under microwave irradiation
A mixture of lithocholic acid (1, 1.27 g, 3.4 mmol) and p-toluene
sulphonyl acid monohydrate (281 mg, 1.5 mmol) in methanol
(80 ml) was irradiated by MW for 6 min at 50% of maximum inten-
sity (i.e. at 375 W). After the evaporation of methanol, water was
water. Recrystallization from ether yielded 1.27 g (97%) of methyl
lithocholate, identical to the product described in the literature,
however, with m.p. 71–73 ◦C where literature mostly gives different
melting points [17] between 115 and 157 ◦C.
Fresh distilled pyridine (5.6 ml, 69 mmol) was added to
the mixture of dry chromium (VI) oxide (2.3 g, 23 mmol) and
dichloromethane (10 ml) at 0 ◦C, and the mixture was stirred until a
suspension was formed. Then methylester of lithocholic acid (1.5 g,
3.85 mmol) dissolved in dichloromethane (40 ml) was added. The
mixture was irradiated by MW for 6 min at 50% of maximum inten-
sity (i.e. at 375 W). Dichloromethane was distilled and the residue
was diluted by diethyl ether (20 ml), filtered through a layer of alu-
mina (30 g) and the filtrate was evaporated and co-evaporated with
toluene (3 × 10 ml). The product was recrystallized from diethyl
ether providing 1.45 g (97%) of methyl 5H-3-oxocholan-24-oate
2 with similar properties to those reported in the literature [18,19].
2.2.3.2. Condensation with pentafluorobenzaldehyde. The reaction
was set using 913 mg (5 mmol) of pentafluorobenzalde-
hyde, 253 mg (0.5 mmol) steroidal dipyrrylmethane 3 in dry
dichloromethane (5 ml) and 154 l TFA. After 3 h, DDQ (116 mg) in
dry dichloromethane (5 ml) was added and the mixture was kept
at room temperature overnight. For purification, 120 g of silica gel
were used in cyclohexane: diethyl ether (24:1 mixture). It yielded
6.1 mg (2%) of product 5 as a brown colored amorphous powder. 1
H
NMR (CDCl3; 400 MHz): 0.64–2.46 m, steroid skeleton; 3.67 s, 3 H,
(24-COOCH3); 5.40–5.60 m (pyrrole); 5.95–6.20 m, (pyrrole); 7.55
m, 1 H (NH-pyrrole); 7.70 m, 1 H (NH-pyrrole). For C80H90F10N4O4
(1361.579) monoisotopic mass 1360.680; found MS: m/z: 1360
(M+.), 1359 (M+−H), 167 (–C6F5).
2.2.3.3. Condensation with acetone. Steroidal dipyrromethane 3
(252 mg, 0.5 mmol) was mixed with 50 ml of dry acetone and 8 l
TFA for 1 h. Chromatography with C6H12:CH2Cl2 1:1 yielded 11 mg
(3%) of 10, as in Section 2.2.3.4.
2.2.2.1. Condensation with pyrrole and BF3·OEt2. BF3·OEt2 (0.61 ml,
6.6 mmol) was slowly added to the mixture of methyl 5H-3-
oxocholan-24-oate (3, 1.3 g, 3.4 mmol) and pyrrole (5 ml) under Ar
and stirring. Stirring was continued for 3.5 h at room temperature
[20]. The mixture was evaporated and co-evaporated with toluene
(4 ml). The residue was dissolved in dichloromethane (20 ml) and
filtered through a small column of silica (10 g). The column was then
washed with dichloromethane (120 ml). Collected filtrates were
evaporated and then chromatographed on a column of silica in
cyclohexane:diethyl ether 9:1. It yielded 462 mg (27%) of product
3 and 123 mg (7%) of its isomer 4 as an amorphous powder. Prod-
uct 3 was identical to the compound described in the literature
[20].
2.2.3.4. MacDonald [2 + 2] condensation with 2,2ꢀ-propane-2,2-
diylbis(1H-pyrrole) and acetone. Steroidal dipyrromethane
3
(249 mg, 0.5 mmol) and 2,2ꢀ-propane-2,2-diylbis(1H-pyrrole) [21]
(176.5 mg, 1.0 mmol) in 50 ml of dry acetone and 8 l TFA were
stirred for 1.5 h. Chromatography on 100 g silica gel in cyclo-
hexane: dichloromethane 2:1 yielded 183 mg of 10 (24%) as a
brownish amorphous powder. 1H NMR (299.97 MHz; pyridine-d5,
see Fig. 1 for atom numbering): 0.88 s, 3 H (18-CH3); 1.08 s, 3
2
H (19-CH3); 1.21 d, JH-H = 6.0, 3 H (21-CH3); 1.98 bs, 18 H (6
CH3-calix[4]pyrrole); 1.05–2.9 m steroid skeleton; 3.96 s, 3 H
(24-COOCH3); 6.14–6.36 m, 8 H); 8.67 bs, NH, 8.84 bs, NH, 9.79
pseudo-d (2 NH). 1H NMR (300 MHz; MeOD): 0.66 s 3 H (18-CH3);
0.90–0.96 bs, 3 H (19-CH3); 0.96–0.98 m, 3 H (21-CH3); 2.11–2.29
m, 2 H (6 CH3-calix[4]pyrrole); 1.0–2.4 m (steroid skeleton); 3.63 s,
5 H (24-COOCH3); 5.49–6.22 m, 8 H (calix[4]pyrrole); 7.21 (dt,
J = 8.50, 2.56 Hz, 1 H) 7.66 (ddd, J = 32.31, 5.64, 3.59 Hz, 1 H); 7.84 (d,
J = 51.29 Hz, 1 H); 8.46 (d, J = 16.41 Hz, 1 H). 13C NMR (75.48 MHz,
MeOD): 12.53, 18; 18.79, 21; 22.03, 11; 25.31, 19; 27.68, 2; –, 15; –,
16; 29.27, 7; 30.27, 23ꢀ; 30.93, 22ꢀ; 31.35, 21ꢀ; 31.77, 20ꢀ; 30.08, 24ꢀ;
29.99, 25ꢀ; 31.88, 22; 31.88, 23; 32.26, 6; 34.08, 1; 36.73, 10; 35.96,
Product 4 was characterized by 1H NMR (CDCl3; 400 MHz):
2
0.64 s, 3 H, (18-CH3); 0.84 s, 3 H, (19-CH3); 0.93 d, JH-H = 4.0, 3
H, (21-CH3); 1.05–2.46 m, steroidal skeleton; 3.67 s, 3 H, (1ꢀꢀ; 24-
COOCH3); 6.02 m 1 H (18ꢀ; pyrrole); 6.13 m, 2 H (2ꢀ + 17ꢀ; pyrrole);
6.50 m, 1 H (16ꢀ; pyrrole); 6.68 m, 1 H (3ꢀ; pyrrole); 6.78 m, 1 H (4ꢀ;
pyrrole); 7.68 bs, 1 H (N1H; pyrrole); 8.13 bs, 1 H (N4H; pyrrole). 13
C
NMR (75.44 MHz, CDCl3): 175.12, 24; 137.64, 19ꢀ; 129.42, 1ꢀ; 118.40,
16ꢀ; 115.89, 4ꢀ; 115.31, 3ꢀ; 108.15, 17ꢀ; 107.82, 18ꢀ; 56.74, 14; 56.15,
17; 51.75, 1ꢀꢀ; 50.39, 9; 42.99, 5; 40.65, 13; 40.65, 3; 40.43, 12; 39.42,
4; 36.04, 20; 35.62, 8; 35.24, 10; 34.32, 1; 32.45, 2; 31.30, 22 + 23;